People · Operator
Named in public records as an officer, director or promoter · active 2018–2020 · Biotechnology, Medical Devices, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Triad Life Sciences Inc. | — | Biotechnology | Series A | $17.1M | $238.3M | 2019 |
| Trilliant Surgical, LLC | — | Medical Devices | Series A | $5.7M | $17.4M | 2018 |
| Precision Healing Inc. | — | Other Health Care | Pre-Seed | $920K | $23.7M | 2020 |
Ron Nixon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Ron Nixon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Kevin Foley | 1 | 8 |
| David George | 1 | 6 |
| Dave Furneaux | 1 | 3 |
| George White | 1 | 3 |
| Dan Wildman | 1 | 2 |
| Donna Best | 1 | 1 |
| Russell Olsen | 1 | 1 |
| Kurt Klitzke | 1 | 1 |
| George M White | 1 | 1 |
| Russell I Olsen | 1 | 1 |
| Donna M Best | 1 | 1 |
| Kevin M Foley, M.D. | 1 | 1 |
| William David Lee | 1 | 1 |
| Mark Carbeau | 1 | 1 |
| Chad Steitle | 1 | 1 |
| Jonathan Olson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.